|
|
Exploring the role of hypoxia signaling and its inhibition as a therapy for Facioscapulohumeral muscular dystrophy |
| 1F32AR079892-01A1 |
|
NIAMS |
2022 |
|
|
Contribution of ribosome specialization to the pathophysiology of muscular dystrophy |
| 1K99AR081367-01 |
|
NIAMS |
2022 |
|
|
Therapeutic genetics and disease modeling in LAMA2-CMD |
| 1R01AR078872-01A1 |
|
NIAMS |
2022 |
|
|
Pathological Foundations of Skeletal Muscle After Volumetric Muscle Loss and Targets For Rehabilitation |
| 1R01AR078903-01A1 |
|
NIAMS |
2022 |
|
|
Targeting PTEN to ameliorate muscular dystrophy in a mouse model |
| 1R01AR079235-01A1 |
|
NIAMS |
2022 |
|
|
Mechanism of Skeletal Muscle Calcium Dysregulation in Myotonic Dystrophy |
| 1R01AR079424-01A1 |
|
NIAMS |
2022 |
|
|
Mechanisms for Regenerative Healing in Intervertebral Discs |
| 1R01AR080096-01 |
|
NIAMS |
2022 |
|
|
Role of Skeletal Muscle Lymphatics in Duchenne Muscular Dystrophy Regulation |
| 1R01AR080129-01 |
|
NIAMS |
2022 |
|
|
Dual-specificity phosphatase action in muscle disease |
| 1R01AR080152-01 |
|
NIAMS |
2022 |
|
|
Ex vivo expansion of skeletal muscle satellite cells |
| 1R21AR079855-01A1 |
|
NIAMS |
2022 |